September 3, 2013 — Several models of defibrillators manufactured by Boston Scientific have been linked to problems with premature battery depletion and malfunctions, with potentially life-threatening consequences.
A hazard alert issued by the Australian Therapeutic Goods Administration (TGA) warns about problems with the Teligen Implantable Cardioverter Defibrillators (ICDs) and Cognis Cardiac Resynchronisation Therapy Defibrillators (CRT-Ds).
Device and model numbers affected include:
- Cognis CRT-D: N106, N107, N118, N119, P106 and P107
- Teligen DR ICD: E110 and F110
- Teligen VR ICD: E102 and F102
The Cognis and Teligen products are Implantable Cardioverter Defibrillators (ICDs), which are medical devices that are implanted in the chest to treat abnormal heart rhythms. When the devices detect a problem, they send a small electrical current to coordinate heart beats and improve the heart’s pumping ability.
This is not the first warning for Boston Scientific defibrillators. In April 2007, about 73,000 defibrillators were recalled due to problems with battery depletion. The U.S. Food and Drug Administration (FDA) also warned in March 2010 that Boston Scientific was recalling all of their ICD and CRT-D defibrillators.
Do I have a Boston Scientific Defibrillator Lawsuit?
The Schmidt Firm, PLLC is currently accepting defective defibrillator induced injury cases in all 50 states. If you or somebody you know has been injured by a Boston Scientific Cognis or Teligen defibrillator, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.